These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 33036706)

  • 1. Effects of exercise on physical outcomes of breast cancer survivors receiving hormone therapy - A systematic review and meta-analysis.
    Boing L; Vieira MCS; Moratelli J; Bergmann A; Guimarães ACA
    Maturitas; 2020 Nov; 141():71-81. PubMed ID: 33036706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis.
    Amir E; Seruga B; Niraula S; Carlsson L; Ocaña A
    J Natl Cancer Inst; 2011 Sep; 103(17):1299-309. PubMed ID: 21743022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine Therapy-Related Symptoms and Quality of Life in Female Cancer Survivors in the Yale Fitness Intervention Trial.
    Park SH; Tish Knobf M; Jeon S
    J Nurs Scholarsh; 2019 May; 51(3):317-325. PubMed ID: 30874369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of exercise on aromatase inhibitor-induced musculoskeletal symptoms in breast cancer survivors :a systematic review and meta-analysis.
    Lu G; Zheng J; Zhang L
    Support Care Cancer; 2020 Apr; 28(4):1587-1596. PubMed ID: 31853701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic review.
    Eisen A; Trudeau M; Shelley W; Messersmith H; Pritchard KI
    Cancer Treat Rev; 2008 Apr; 34(2):157-74. PubMed ID: 18164821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone health management of Australian breast cancer survivors receiving hormonal therapy.
    Roberts R; Miller M; O'Callaghan M; Koczwara B
    Intern Med J; 2015 Nov; 45(11):1182-5. PubMed ID: 26348867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine-related quality of life in a randomized trial of exercise on aromatase inhibitor-induced arthralgias in breast cancer survivors.
    Baglia ML; Lin IH; Cartmel B; Sanft T; Ligibel J; Hershman DL; Harrigan M; Ferrucci LM; Li FY; Irwin ML
    Cancer; 2019 Jul; 125(13):2262-2271. PubMed ID: 30840336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of cardiovascular disease in breast cancer patients receiving aromatase inhibitors vs. tamoxifen: A systematic review and meta-analysis.
    Yu Q; Xu Y; Yu E; Zheng Z
    J Clin Pharm Ther; 2022 May; 47(5):575-587. PubMed ID: 34984740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone therapy and osteoporosis in breast cancer survivors: assessment of risk and adherence to screening recommendations.
    Hamood R; Hamood H; Merhasin I; Keinan-Boker L
    Osteoporos Int; 2019 Jan; 30(1):187-200. PubMed ID: 30413856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial.
    Dieli-Conwright CM; Courneya KS; Demark-Wahnefried W; Sami N; Lee K; Sweeney FC; Stewart C; Buchanan TA; Spicer D; Tripathy D; Bernstein L; Mortimer JE
    Breast Cancer Res; 2018 Oct; 20(1):124. PubMed ID: 30340503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical exercise training interventions for children and young adults during and after treatment for childhood cancer.
    Braam KI; van der Torre P; Takken T; Veening MA; van Dulmen-den Broeder E; Kaspers GJ
    Cochrane Database Syst Rev; 2013 Apr; (4):CD008796. PubMed ID: 23633361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Aerobic and Resistance Training Improves Body Composition, Alters Cardiometabolic Risk, and Ameliorates Cancer-Related Indicators in Breast Cancer Patients and Survivors with Overweight/Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Al-Mhanna SB; Batrakoulis A; Norhayati MN; Mohamed M; Drenowatz C; Irekeola AA; Afolabi HA; Gülü M; Alkhamees NH; Wan Ghazali WS
    J Sports Sci Med; 2024 Jun; 23(2):366-395. PubMed ID: 38841642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of an exercise program on quality of life in older breast cancer survivors undergoing aromatase inhibitor therapy: a randomized controlled trial.
    Paulo TRS; Rossi FE; Viezel J; Tosello GT; Seidinger SC; Simões RR; de Freitas R; Freitas IF
    Health Qual Life Outcomes; 2019 Jan; 17(1):17. PubMed ID: 30658629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials.
    Khosrow-Khavar F; Filion KB; Al-Qurashi S; Torabi N; Bouganim N; Suissa S; Azoulay L
    Ann Oncol; 2017 Mar; 28(3):487-496. PubMed ID: 27998966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cardiac Rehabilitation Model Improves Fitness, Quality of Life, and Depression in Breast Cancer Survivors.
    Dolan LB; Barry D; Petrella T; Davey L; Minnes A; Yantzi A; Marzolini S; Oh P
    J Cardiopulm Rehabil Prev; 2018 Jul; 38(4):246-252. PubMed ID: 28525464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing exercise responses to aerobic plus resistance training between postmenopausal breast cancer survivors undergoing aromatase inhibitor therapy and healthy women.
    de Paulo TRS; Winters-Stone KM; Viezel J; Rossi FE; Aro BL; Trindade ACAC; Codogno JS; Freitas Junior IF
    Disabil Rehabil; 2019 Sep; 41(18):2175-2182. PubMed ID: 29644889
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic options for aromatase inhibitor-associated arthralgia in breast cancer survivors: A systematic review of systematic reviews, evidence mapping, and network meta-analysis.
    Kim TH; Kang JW; Lee TH
    Maturitas; 2018 Dec; 118():29-37. PubMed ID: 30415752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of YOCAS©® yoga for musculoskeletal symptoms among breast cancer survivors on hormonal therapy.
    Peppone LJ; Janelsins MC; Kamen C; Mohile SG; Sprod LK; Gewandter JS; Kirshner JJ; Gaur R; Ruzich J; Esparaz BT; Mustian KM
    Breast Cancer Res Treat; 2015 Apr; 150(3):597-604. PubMed ID: 25814054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment utilization and non-drug interventions for vasomotor symptoms in breast cancer survivors taking endocrine therapy: Real-world findings from the United States and Europe.
    Kingsberg S; Banks V; Caetano C; Janssenswillen C; Moeller C; Schoof N; Harvey M; Scott M; Nappi RE
    Maturitas; 2024 Oct; 188():108071. PubMed ID: 39059108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI.
    Lintermans A; Van Asten K; Wildiers H; Laenen A; Paridaens R; Weltens C; Verhaeghe J; Vanderschueren D; Smeets A; Van Limbergen E; Leunen K; Christiaens MR; Neven P
    Breast Cancer Res Treat; 2014 Jul; 146(1):109-16. PubMed ID: 24816806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.